Taiwan Semiconductor and ASML Are Incredible, but 1 of These Monopoly Chip Stocks Is Far Safer.

The article favors Taiwan Semiconductor Manufacturing over ASML as the safer investment, citing TSMC's approximately 72.5% share of chip-fabrication industry revenue in Q2 and its scale advantage. It argues ASML's machine sales depend more on continued capacity expansion, which could slow after the AI build-out, while TSMC trades at a lower valuation than ASML on 2026 and 2027 earnings estimates. The comparison is an investment opinion; no new earnings results or company guidance are reported.

Analysis

The key distinction is not monopoly strength but where each company sits in the capex cycle. ASML monetizes customers’ decisions to add or upgrade leading-edge capacity; a pause can delay new-system orders even while its installed base continues to generate service and upgrade revenue. That makes order intake and cancellations more informative near term than the long-run technological moat. TSMC captures utilization, process mix and pricing as well as capacity growth, but its scale does not insulate it from underused fabs, customer bargaining, or the heavy reinvestment needed to stay at the frontier. A relative preference for TSM therefore depends on sustained leading-edge utilization and returns on new capacity—not simply on alternative chip applications eventually emerging.

The article’s “AI build-out complete” framing is a weak timing anchor: spending could rotate among accelerators, networking, memory and inference rather than stop, while fab additions arrive with long lags. Conversely, AI demand can disappoint before new capacity is absorbed. ASML’s service base and future tool upgrades may cushion a downturn; TSM’s Taiwan concentration adds a low-frequency, high-severity risk that the valuation comparison does not resolve. Over 1–3 months, watch ASML bookings/backlog conversion and both companies’ capex and utilization commentary. Over 6–18 months, monitor leading-edge capacity absorption, customer concentration and any evidence of competing foundry capacity gaining credible scale. The relative-value thesis fails if ASML’s service/upgrade mix sustains growth through weaker tool orders, or if TSM’s utilization, pricing or returns deteriorate. Valuation claims require current, like-for-like forward estimates and multiples; the article alone does not establish an attractive entry.

Key Decisions for Investors

• Treat long TSM/short ASML as a conditional relative-value setup, not an unconditional recommendation: first verify the forward-multiple spread, earnings-estimate quality and current beta relationship, then size the pair to limit broad semiconductor exposure.
• For the next 1–3 months, use ASML order intake, backlog conversion and management commentary on customer capacity plans as the main catalyst checks; a sharp deterioration would support the short leg, while resilient upgrades and services would weaken it.
• Track TSM leading-edge utilization, process mix, capex returns and customer commitments. If utilization or pricing weakens despite continued AI-related demand, reduce or avoid the long leg; expanding credible capacity at competing foundries would also challenge the scale thesis.
• Do not extrapolate future robotics or autonomous-driving demand into near-term earnings. Revisit that upside only when customer programs translate into verifiable wafer demand; separately stress-test TSM for Taiwan geopolitical disruption, which can overwhelm ordinary valuation and operating analysis.